RFX6 and posterior cortical atrophy: Moreover, high RFX6 levels were linked to shorter progression‐free survival in PCa patients[55] (Figure 2g), corroborating its association with biochemical relapse,[33, 56] thereby highlighting the strong connection between RFX6 expression and PCa clinical severity.